Clinical Trial: Prospective, Single-Arm Clinical Study on the Efficacy and Safety of Hepatic Artery Infusion Chemotherapy (HAIC) as Adjuvant Therapy After Radical Resection of Extrahepatic Biliary Tract Cancer (China)

Posted On: 2026-10-12

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective, Single-Arm Clinical Study on the Efficacy and Safety of Hepatic Artery Infusion Chemotherapy (HAIC) as Adjuvant Therapy After Radical Resection of Extrahepatic Biliary Tract Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134161

Registration Time: 2026/10/11

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=292725

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Prospective, Single-Arm Clinical Study on the Efficacy and Safety of Hepatic Artery Infusion Chemotherapy (HAIC) as Adjuvant Therapy After Radical Resection of Extrahepatic Biliary Tract Cancer (China)